Drug intelligence / Profile preview

Shenqi Heji

Development stage: Unknown
Lead developer: Shaanxi Buchang Group
Administration: Oral

Overview

Shenqi Heji is a Traditional Chinese Medicine (TCM) oral liquid formulation developed and manufactured by Shaanxi Buchang Group. It is primarily utilized as a supportive care therapeutic for cancer patients, specifically indicated to address symptoms of Qi and blood deficiency that frequently occur following chemotherapy or radiotherapy. The formulation is designed to tonify the spleen, replenish vital energy (Qi), and support immune function, thereby helping to alleviate cancer-related fatigue and improve the overall quality of life. As a proprietary Chinese medicine, it represents a standardized herbal decoction-style formulation intended for oral administration within the oncology supportive care setting.

Brand names: Shenqi Heji
Other names: 参芪合剂Shenqi He Ji

Beyond the preview

Go deeper on Shenqi Heji.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenqi Heji.

Explore the full profile